Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.7%

2 terminated out of 35 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

30%

3 of 10 completed with results

Key Signals

3 with results83% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (12)
Early P 1 (1)
P 1 (4)
P 2 (5)

Trial Status

Recruiting11
Completed10
Active Not Recruiting9
Terminated2
Not Yet Recruiting1
Suspended1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT05509751Not ApplicableActive Not Recruiting

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

NCT04235777Phase 1Recruiting

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

NCT07389525Early Phase 1Not Yet Recruiting

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

NCT07524114Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

NCT06253520Phase 1Active Not Recruiting

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

NCT04020978Not ApplicableCompletedPrimary

Parametric PET of Genitourinary Cancer

NCT07447050Phase 2Recruiting

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

NCT04354064Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

NCT07111039Not ApplicableSuspended

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

NCT04923178Recruiting

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT06795087RecruitingPrimary

Discharge Medication Use Post-Operatively in GU Cancer Patients

NCT03333616Phase 2Active Not RecruitingPrimary

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

NCT01505400Active Not Recruiting

Integrated Molecular Profiling in Advanced Cancers Trial

NCT05707286Completed

Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy

NCT03794635Not ApplicableActive Not Recruiting

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

NCT02735252Not ApplicableActive Not Recruiting

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

NCT04273061Phase 2Recruiting

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

NCT05629065Not ApplicableActive Not Recruiting

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

NCT06384417Not ApplicableActive Not Recruiting

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

NCT06580002Phase 2Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Scroll to load more

Research Network

Activity Timeline